Selected research
Industry Research
Biological Evaluation Services Industry Research Report 2026
Market perspective
The global Biological Evaluation Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biological Evaluation Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biological Evaluation Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biological Evaluation Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biological Evaluation Services include Charles River Laboratories, Labcorp, Namsa, SGS SA, TVU SUD, SenzaGen, LFH Regulatory, Med Institute and SCC Medical Devices, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biological Evaluation Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biological Evaluation Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biological Evaluation Services Market by Company
Charles River Laboratories
Labcorp
Namsa
SGS SA
TVU SUD
SenzaGen
LFH Regulatory
Med Institute
SCC Medical Devices
Measurlabs
Sushvin
GBA Key2Compliance
Qserve
Thinqbetter
Groenakker
JordiLabs, LLC
Biotox Laboratories
Gnovo
Yimeida Meoical Device Consulting
Prima Drug Research Center
Mid Link
WuXi AppTec Medical Device Testing Center
Biological Evaluation Services Segment by Type
Toxicology Evaluation
Safety Pharmacology
Immunology Evaluation
Others
Biological Evaluation Services Segment by Application
Drugs
Medical Devices
Diagnostic Reagents
Biomaterials
Others
Biological Evaluation Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Evaluation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biological Evaluation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Evaluation Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biological Evaluation Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Toxicology Evaluation
- Safety Pharmacology
- Immunology Evaluation
- Others
Applications
- Drugs
- Medical Devices
- Diagnostic Reagents
- Biomaterials
- Others
Companies covered
- Charles River Laboratories
- Labcorp
- Namsa
- SGS SA
- TVU SUD
- SenzaGen
- LFH Regulatory
- Med Institute
- SCC Medical Devices
- Measurlabs
- Sushvin
- GBA Key2Compliance
- Qserve
- Thinqbetter
- Groenakker
- JordiLabs, LLC
- Biotox Laboratories
- Gnovo
- Yimeida Meoical Device Consulting
- Prima Drug Research Center
- Mid Link
- WuXi AppTec Medical Device Testing Center
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biological Evaluation Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Toxicology Evaluation
- 2.2.3 Safety Pharmacology
- 2.2.4 Immunology Evaluation
- 2.2.5 Others
- 2.3 Biological Evaluation Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drugs
- 2.3.3 Medical Devices
- 2.3.4 Diagnostic Reagents
- 2.3.5 Biomaterials
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Biological Evaluation Services Breakdown Data by Type
- 3.1 Global Biological Evaluation Services Historic Market Size by Type (2021-2026)
- 3.2 Global Biological Evaluation Services Forecasted Market Size by Type (2027-2032)
4 Biological Evaluation Services Breakdown Data by Application
- 4.1 Global Biological Evaluation Services Historic Market Size by Application (2021-2026)
- 4.2 Global Biological Evaluation Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biological Evaluation Services Market Perspective (2021-2032)
- 5.2 Global Biological Evaluation Services Growth Trends by Region
- 5.2.1 Global Biological Evaluation Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biological Evaluation Services Historic Market Size by Region (2021-2026)
- 5.2.3 Biological Evaluation Services Forecasted Market Size by Region (2027-2032)
- 5.3 Biological Evaluation Services Market Dynamics
- 5.3.1 Biological Evaluation Services Industry Trends
- 5.3.2 Biological Evaluation Services Market Drivers
- 5.3.3 Biological Evaluation Services Market Challenges
- 5.3.4 Biological Evaluation Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biological Evaluation Services Players by Revenue
- 6.1.1 Global Top Biological Evaluation Services Players by Revenue (2021-2026)
- 6.1.2 Global Biological Evaluation Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Biological Evaluation Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biological Evaluation Services Head Office and Area Served
- 6.4 Global Biological Evaluation Services Players, Product Type & Application
- 6.5 Global Biological Evaluation Services Manufacturers Established Date
- 6.6 Global Biological Evaluation Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biological Evaluation Services Market Size (2021-2032)
- 7.2 North America Biological Evaluation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biological Evaluation Services Market Size by Country (2021-2026)
- 7.4 North America Biological Evaluation Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biological Evaluation Services Market Size (2021-2032)
- 8.2 Europe Biological Evaluation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biological Evaluation Services Market Size by Country (2021-2026)
- 8.4 Europe Biological Evaluation Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biological Evaluation Services Market Size (2021-2032)
- 9.2 Asia-Pacific Biological Evaluation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biological Evaluation Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biological Evaluation Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biological Evaluation Services Market Size (2021-2032)
- 10.2 South America Biological Evaluation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biological Evaluation Services Market Size by Country (2021-2026)
- 10.4 South America Biological Evaluation Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biological Evaluation Services Market Size (2021-2032)
- 11.2 Middle East & Africa Biological Evaluation Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biological Evaluation Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biological Evaluation Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Biological Evaluation Services Business (2021-2026)
- 12.1.4 Charles River Laboratories Biological Evaluation Services Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 Labcorp
- 12.2.1 Labcorp Company Information
- 12.2.2 Labcorp Business Overview
- 12.2.3 Labcorp Revenue in Biological Evaluation Services Business (2021-2026)
- 12.2.4 Labcorp Biological Evaluation Services Product Portfolio
- 12.2.5 Labcorp Recent Developments
- 12.3 Namsa
- 12.3.1 Namsa Company Information
- 12.3.2 Namsa Business Overview
- 12.3.3 Namsa Revenue in Biological Evaluation Services Business (2021-2026)
- 12.3.4 Namsa Biological Evaluation Services Product Portfolio
- 12.3.5 Namsa Recent Developments
- 12.4 SGS SA
- 12.4.1 SGS SA Company Information
- 12.4.2 SGS SA Business Overview
- 12.4.3 SGS SA Revenue in Biological Evaluation Services Business (2021-2026)
- 12.4.4 SGS SA Biological Evaluation Services Product Portfolio
- 12.4.5 SGS SA Recent Developments
- 12.5 TVU SUD
- 12.5.1 TVU SUD Company Information
- 12.5.2 TVU SUD Business Overview
- 12.5.3 TVU SUD Revenue in Biological Evaluation Services Business (2021-2026)
- 12.5.4 TVU SUD Biological Evaluation Services Product Portfolio
- 12.5.5 TVU SUD Recent Developments
- 12.6 SenzaGen
- 12.6.1 SenzaGen Company Information
- 12.6.2 SenzaGen Business Overview
- 12.6.3 SenzaGen Revenue in Biological Evaluation Services Business (2021-2026)
- 12.6.4 SenzaGen Biological Evaluation Services Product Portfolio
- 12.6.5 SenzaGen Recent Developments
- 12.7 LFH Regulatory
- 12.7.1 LFH Regulatory Company Information
- 12.7.2 LFH Regulatory Business Overview
- 12.7.3 LFH Regulatory Revenue in Biological Evaluation Services Business (2021-2026)
- 12.7.4 LFH Regulatory Biological Evaluation Services Product Portfolio
- 12.7.5 LFH Regulatory Recent Developments
- 12.8 Med Institute
- 12.8.1 Med Institute Company Information
- 12.8.2 Med Institute Business Overview
- 12.8.3 Med Institute Revenue in Biological Evaluation Services Business (2021-2026)
- 12.8.4 Med Institute Biological Evaluation Services Product Portfolio
- 12.8.5 Med Institute Recent Developments
- 12.9 SCC Medical Devices
- 12.9.1 SCC Medical Devices Company Information
- 12.9.2 SCC Medical Devices Business Overview
- 12.9.3 SCC Medical Devices Revenue in Biological Evaluation Services Business (2021-2026)
- 12.9.4 SCC Medical Devices Biological Evaluation Services Product Portfolio
- 12.9.5 SCC Medical Devices Recent Developments
- 12.10 Measurlabs
- 12.10.1 Measurlabs Company Information
- 12.10.2 Measurlabs Business Overview
- 12.10.3 Measurlabs Revenue in Biological Evaluation Services Business (2021-2026)
- 12.10.4 Measurlabs Biological Evaluation Services Product Portfolio
- 12.10.5 Measurlabs Recent Developments
- 12.11 Sushvin
- 12.11.1 Sushvin Company Information
- 12.11.2 Sushvin Business Overview
- 12.11.3 Sushvin Revenue in Biological Evaluation Services Business (2021-2026)
- 12.11.4 Sushvin Biological Evaluation Services Product Portfolio
- 12.11.5 Sushvin Recent Developments
- 12.12 GBA Key2Compliance
- 12.12.1 GBA Key2Compliance Company Information
- 12.12.2 GBA Key2Compliance Business Overview
- 12.12.3 GBA Key2Compliance Revenue in Biological Evaluation Services Business (2021-2026)
- 12.12.4 GBA Key2Compliance Biological Evaluation Services Product Portfolio
- 12.12.5 GBA Key2Compliance Recent Developments
- 12.13 Qserve
- 12.13.1 Qserve Company Information
- 12.13.2 Qserve Business Overview
- 12.13.3 Qserve Revenue in Biological Evaluation Services Business (2021-2026)
- 12.13.4 Qserve Biological Evaluation Services Product Portfolio
- 12.13.5 Qserve Recent Developments
- 12.14 Thinqbetter
- 12.14.1 Thinqbetter Company Information
- 12.14.2 Thinqbetter Business Overview
- 12.14.3 Thinqbetter Revenue in Biological Evaluation Services Business (2021-2026)
- 12.14.4 Thinqbetter Biological Evaluation Services Product Portfolio
- 12.14.5 Thinqbetter Recent Developments
- 12.15 Groenakker
- 12.15.1 Groenakker Company Information
- 12.15.2 Groenakker Business Overview
- 12.15.3 Groenakker Revenue in Biological Evaluation Services Business (2021-2026)
- 12.15.4 Groenakker Biological Evaluation Services Product Portfolio
- 12.15.5 Groenakker Recent Developments
- 12.16 JordiLabs, LLC
- 12.16.1 JordiLabs, LLC Company Information
- 12.16.2 JordiLabs, LLC Business Overview
- 12.16.3 JordiLabs, LLC Revenue in Biological Evaluation Services Business (2021-2026)
- 12.16.4 JordiLabs, LLC Biological Evaluation Services Product Portfolio
- 12.16.5 JordiLabs, LLC Recent Developments
- 12.17 Biotox Laboratories
- 12.17.1 Biotox Laboratories Company Information
- 12.17.2 Biotox Laboratories Business Overview
- 12.17.3 Biotox Laboratories Revenue in Biological Evaluation Services Business (2021-2026)
- 12.17.4 Biotox Laboratories Biological Evaluation Services Product Portfolio
- 12.17.5 Biotox Laboratories Recent Developments
- 12.18 Gnovo
- 12.18.1 Gnovo Company Information
- 12.18.2 Gnovo Business Overview
- 12.18.3 Gnovo Revenue in Biological Evaluation Services Business (2021-2026)
- 12.18.4 Gnovo Biological Evaluation Services Product Portfolio
- 12.18.5 Gnovo Recent Developments
- 12.19 Yimeida Meoical Device Consulting
- 12.19.1 Yimeida Meoical Device Consulting Company Information
- 12.19.2 Yimeida Meoical Device Consulting Business Overview
- 12.19.3 Yimeida Meoical Device Consulting Revenue in Biological Evaluation Services Business (2021-2026)
- 12.19.4 Yimeida Meoical Device Consulting Biological Evaluation Services Product Portfolio
- 12.19.5 Yimeida Meoical Device Consulting Recent Developments
- 12.20 Prima Drug Research Center
- 12.20.1 Prima Drug Research Center Company Information
- 12.20.2 Prima Drug Research Center Business Overview
- 12.20.3 Prima Drug Research Center Revenue in Biological Evaluation Services Business (2021-2026)
- 12.20.4 Prima Drug Research Center Biological Evaluation Services Product Portfolio
- 12.20.5 Prima Drug Research Center Recent Developments
- 12.21 Mid Link
- 12.21.1 Mid Link Company Information
- 12.21.2 Mid Link Business Overview
- 12.21.3 Mid Link Revenue in Biological Evaluation Services Business (2021-2026)
- 12.21.4 Mid Link Biological Evaluation Services Product Portfolio
- 12.21.5 Mid Link Recent Developments
- 12.22 WuXi AppTec Medical Device Testing Center
- 12.22.1 WuXi AppTec Medical Device Testing Center Company Information
- 12.22.2 WuXi AppTec Medical Device Testing Center Business Overview
- 12.22.3 WuXi AppTec Medical Device Testing Center Revenue in Biological Evaluation Services Business (2021-2026)
- 12.22.4 WuXi AppTec Medical Device Testing Center Biological Evaluation Services Product Portfolio
- 12.22.5 WuXi AppTec Medical Device Testing Center Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst